Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $67,963 | 22 | 78.9% |
| Food and Beverage | $11,152 | 543 | 12.9% |
| Travel and Lodging | $6,451 | 26 | 7.5% |
| Education | $600.82 | 16 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $75,214 | 62 | $0 (2024) |
| Astellas Pharma US Inc | $1,681 | 90 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $1,218 | 65 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $758.83 | 35 | $0 (2024) |
| Janssen Biotech, Inc. | $740.64 | 45 | $0 (2024) |
| Coloplast Corp | $656.88 | 23 | $0 (2022) |
| Boston Scientific Corporation | $503.80 | 16 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $384.84 | 20 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $372.74 | 22 | $0 (2024) |
| PFIZER INC. | $273.99 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,844 | 48 | Stryker Corporation ($750.00) |
| 2023 | $1,452 | 71 | Myriad Genetic Laboratories, Inc. ($215.87) |
| 2022 | $24,771 | 113 | Stryker Corporation ($23,026) |
| 2021 | $32,636 | 114 | Stryker Corporation ($30,815) |
| 2020 | $9,203 | 67 | Stryker Corporation ($7,936) |
| 2019 | $6,582 | 59 | Stryker Corporation ($5,250) |
| 2018 | $8,638 | 73 | Stryker Corporation ($7,438) |
| 2017 | $1,040 | 62 | Endo Pharmaceuticals Inc. ($314.78) |
All Payment Transactions
607 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $52.79 | General |
| 12/12/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: HORMONE THERAPY | ||||||
| 11/29/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: HORMONE THERAPY | ||||||
| 11/19/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $16.15 | General |
| Category: Prostate cancer | ||||||
| 10/31/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: UROLOGY | ||||||
| 10/29/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Urology | ||||||
| 09/10/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $32.16 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $18.84 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $22.29 | General |
| 08/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Oncology | ||||||
| 08/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $26.99 | General |
| 07/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/23/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: ONCOLOGY | ||||||
| 06/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Oncology | ||||||
| 06/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Oncology | ||||||
| 06/10/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,829 | 5,983 | $325,129 | $138,826 |
| 2022 | 19 | 1,566 | 4,636 | $269,202 | $113,400 |
| 2021 | 21 | 1,677 | 4,788 | $255,588 | $108,354 |
| 2020 | 20 | 1,405 | 4,057 | $202,647 | $78,622 |
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 394 | 653 | $104,690 | $62,248 | 59.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 88 | 101 | $40,400 | $18,823 | 46.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 138 | 138 | $36,570 | $16,525 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 168 | 202 | $20,200 | $13,139 | 65.0% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 33 | 33 | $28,050 | $6,690 | 23.9% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 13 | $15,600 | $4,365 | 28.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 25 | $5,875 | $3,420 | 58.2% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 30 | 30 | $12,900 | $2,470 | 19.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 425 | 670 | $6,700 | $2,265 | 33.8% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 68 | 71 | $13,774 | $1,637 | 11.9% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 16 | 16 | $6,960 | $1,584 | 22.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 152 | 200 | $7,000 | $1,554 | 22.2% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 82 | 101 | $15,150 | $1,063 | 7.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 21 | 56 | $2,240 | $939.64 | 41.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 58 | 60 | $480.00 | $470.40 | 98.0% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 17 | 20 | $1,200 | $464.02 | 38.7% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 33 | 3,500 | $2,100 | $414.26 | 19.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 15 | 15 | $3,930 | $359.66 | 9.2% |
| 82565 | Blood creatinine level | Office | 2023 | 32 | 34 | $510.00 | $170.68 | 33.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 14 | $490.00 | $156.10 | 31.9% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 15 | 31 | $310.00 | $69.49 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 355 | 560 | $89,600 | $51,038 | 57.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 75 | 87 | $34,800 | $16,830 | 48.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 91 | 91 | $24,115 | $10,902 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 134 | 160 | $16,000 | $10,251 | 64.1% |
About Dr. Albert Ong, M.D
Dr. Albert Ong, M.D is a Urology healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053365767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Ong, M.D has received a total of $86,166 in payments from pharmaceutical and medical device companies, with $1,844 received in 2024. These payments were reported across 607 transactions from 66 companies. The most common payment nature is "Consulting Fee" ($67,963).
As a Medicare-enrolled provider, Ong has provided services to 6,477 Medicare beneficiaries, totaling 19,464 services with total Medicare billing of $439,202. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology, Urology
- Location Orlando, FL
- Active Since 05/19/2006
- Last Updated 08/29/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1053365767
Products in Payments
- IRIS (Device) $30,671
- UKIT (Device) $10,905
- AIM (ADVANCED IMAGING MODALITY) (Device) $10,567
- AIM LAPARASCOPES (Device) $9,100
- SPY-PHI SYSTEM (Device) $5,342
- XIAFLEX (Biological) $786.29
- 1788 (Medical Supply) $750.00
- XTANDI (Drug) $677.47
- SPY TECHNOLOGY (Device) $530.95
- ERLEADA (Drug) $478.29
- AVEED (Biological) $475.43
- ELIGARD (Drug) $458.19
- Myrbetriq (Drug) $456.36
- ORGOVYX (Drug) $432.73
- Nubeqa (Drug) $372.74
- MYRISK (Device) $360.57
- SpeediCath (Device) $291.67
- PROVENGE (Drug) $266.74
- BOTOX (Biological) $263.54
- Natesto (Drug) $245.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Orlando
Dr. Olubayo Tojuola, M.d, M.D
Urology — Payments: $213,572
Jeffrey Brady, M.d, M.D
Urology — Payments: $135,720
Dr. Lucas Wiegand, Md, MD
Urology — Payments: $103,853
Christopher Russell, Md, MD
Urology — Payments: $24,045
Stephen Baker, Md, MD
Urology — Payments: $20,508
Dr. Benjamin Rhee, M.d, M.D
Urology — Payments: $20,210